Sofinnova Investments, Inc.

Position in CMPX — Compass Therapeutics, Inc.

CIK 1631134 Menlo Park, CA

Back to CMPX Full portfolio

Position in CMPX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,877,091

-$7,195,354 QoQ

Shares Held

2,056,161

-38.9% QoQ

Ownership

1.14%

of shares outstanding

% of Portfolio

0.55%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in CMPX Over Time

Shares Held

Position Value (USD)

Derivatives in CMPX

reported options exposure · as of Mar 31, 2026

CallValue

$2,645,000

CallShares

500,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Sofinnova Investments, Inc. holds $1,182,454,857 across 43 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	VERA	Vera Therapeutics, Inc.	2,793,987	$119,889,982
2	GMAB	Genmab A/S	4,045,215	$111,122,056
3	JAZZ	Jazz Pharmaceuticals plc	365,341	$88,036,220
4	RAPP	Rapport Therapeutics, Inc.	1,904,408	$79,356,681
5	SPTX	Seaport Therapeutics, Inc.	3,564,871	$77,428,998
6	AVBP	ArriVent BioPharma, Inc.	1,696,752	$58,945,164
7	RARE	Ultragenyx Pharmaceutical Inc.	1,717,505	$57,347,491
8	RYTM	Rhythm Pharmaceuticals, Inc.	408,027	$45,303,237

All Filings in CMPX

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,877,091	2,056,161	-38.9%	Shares	Sole	2026-05-15
2026-03-31	$2,645,000	500,000	—	Call	Sole	2026-05-15
2025-12-31	$18,072,445	3,365,446	+65.9%	Shares	Sole	2026-02-13
2025-09-30	$7,101,101	2,028,886	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.